Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Marianna ADAMO"'
Autor:
Giulio Savonitto, Davide Barbisan, Pietro Ameri, Carlo Maria Lombardi, Simonetta Monti, Mauro Driussi, Piero Gentile, Luke Howard, Matteo Toma, Matteo Pagnesi, Valentino Collini, Carolina Bauleo, Marianna Adamo, Luciana D'Angelo, Chiara Nalli, Alberto Giannoni, Veronica Vecchiato, Emma Di Poi, Edoardo Airo, Marco Metra, Andrea Garascia, Gianfranco Sinagra, Francesco Lo Giudice, Davide Stolfo
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 3146-3154 (2024)
Abstract Aims The use of loop diuretics in pulmonary arterial hypertension (PAH) is less frequent compared with heart failure. The clinical and prognostic characteristics of PAH patients according to loop diuretic use remain unexplored. In this study
Externí odkaz:
https://doaj.org/article/4ba28a48e3514ab3a76269db2c063ccc
Autor:
Karl‐Patrik Kresoja, Marianna Adamo, Karl‐Phillipp Rommel, Lukas Stolz, Nicole Karam, Cristina Giannini, Bruno Melica, Ralph Stephan vonBardeleben, Christian Butter, Patrick Horn, Fabien Praz, Daniel Kalbacher, Christos Iliadis, Holger Thiele, Jörg Hausleiter, Marco Metra, Philipp Lurz
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1802-1807 (2024)
Abstract Aims Achieving optimized guideline‐directed medical therapy (GDMT) is recommended prior to transcatheter mitral valve edge‐to‐edge repair (M‐TEER) for secondary mitral regurgitation (SMR). We aimed to propose and validate an easy‐t
Externí odkaz:
https://doaj.org/article/f1a77ca3da5c4767bf3aa81d1a35bcd2
Autor:
Giuliana Cimino, Muthiah Vaduganathan, Carlo M. Lombardi, Matteo Pagnesi, Enrico Vizzardi, Daniela Tomasoni, Marianna Adamo, Marco Metra, Riccardo M. Inciardi
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 649-661 (2024)
Abstract Heart failure with preserved ejection fraction (HFpEF) has a high prevalence, affecting more than 50% of patients with heart failure. HFpEF is associated with multiple comorbidities, and obesity is one of the most common. A distinct phenotyp
Externí odkaz:
https://doaj.org/article/4b960ada66b345948d2cb42dd058ab2a
Autor:
Matteo Pagnesi, Carlo Mario Lombardi, Chiara Tedino, Mauro Chiarito, Davide Stolfo, Luca Baldetti, Marianna Adamo, Filippo Calì, Riccardo Maria Inciardi, Daniela Tomasoni, Ferdinando Loiacono, Marta Maccallini, Alessandro Villaschi, Gaia Gasparini, Marco Montella, Stefano Contessi, Daniele Cocianni, Maria Perotto, Giuseppe Barone, Marco Merlo, Alberto Maria Cappelletti, Gianfranco Sinagra, Daniela Pini, Marco Metra
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 136-146 (2024)
Abstract Aims Patients with heart failure (HF) with reduced ejection fraction (EF) (HFrEF), mildly reduced EF (HFmrEF), and preserved EF (HFpEF) may all progress to advanced HF, but the impact of EF in the advanced setting is not well established. Ou
Externí odkaz:
https://doaj.org/article/d9cacd29f711408ebe14196669c93abd
Autor:
Arturo Giordano, Paolo Ferraro, Filippo Finizio, Nicola Corcione, Michele Cimmino, Giuseppe Biondi‐Zoccai, Paolo Denti, Antonio Popolo Rubbio, Anna Sonia Petronio, Antonio L. Bartorelli, Annalisa Mongiardo, Salvatore Giordano, Francesco De Felice, Marianna Adamo, Matteo Montorfano, Cesare Baldi, Giuseppe Tarantini, Francesco Giannini, Federico Ronco, Ida Monteforte, Emmanuel Villa, Maurizio Ferrario, Luigi Fiocca, Fausto Castriota, Angelo Squeri, Corrado Tamburino, Francesco Bedogni
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 10 (2024)
Background Minimally invasive mitral valve repair has a favorable risk–benefit profile in patients with significant de novo mitral regurgitation. Its role in patients with prior mitral valve repair is uncertain. We aimed to appraise the outcome of
Externí odkaz:
https://doaj.org/article/988888bf04db4e29b924608655b5717e
Autor:
Manuel Garofalo, Rossana Corso, Daniela Tomasoni, Marianna Adamo, Carlo M. Lombardi, Riccardo M. Inciardi, Cristina Gussago, Carlo Di Mario, Marco Metra, Matteo Pagnesi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Acute heart failure (AHF) represents a common clinical scenario that requires prompt evaluation and therapy and that is characterized by a high risk of mortality or subsequent rehospitalizations. The pathophysiology leading to AHF decompensation is s
Externí odkaz:
https://doaj.org/article/1f66cae904a54e1491023a5bb2c3397e
Autor:
Mauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, Marianna Adamo, Matteo Pagnesi, Giuseppe Rosano, Marco Metra, Stephan vonHaehling, Daniela Tomasoni
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 3667-3693 (2022)
Abstract In the last years, major progress occurred in heart failure (HF) management. Quadruple therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst verciguat is becoming available across several countries, ome
Externí odkaz:
https://doaj.org/article/f6cfb0c4bf9c4d41b0a099e0feb44f9c
Autor:
Alberto Palazzuoli, Marco Metra, Sean P. Collins, Marianna Adamo, Andrew P. Ambrosy, Laura E. Antohi, Tuvia Ben Gal, Dimitrios Farmakis, Finn Gustafsson, Loreena Hill, Yuri Lopatin, Francesco Tramonte, Alexander Lyon, Josep Masip, Oscar Miro, Brenda Moura, Wilfried Mullens, Razvan I. Radu, Magdy Abdelhamid, Stefan Anker, Ovidiu Chioncel
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 3713-3736 (2022)
Abstract The coronavirus 2019 (COVID‐19) infection pandemic has affected the care of patients with heart failure (HF). Several consensus documents describe the appropriate diagnostic algorithm and treatment approach for patients with HF and associa
Externí odkaz:
https://doaj.org/article/f52dd99e17794c7e9f1e8076d1fb0a29
Autor:
Daniela Tomasoni, Giovanni Battista Bonfioli, Alberto Aimo, Marianna Adamo, Marco Canepa, Riccardo M. Inciardi, Carlo Mario Lombardi, Matilde Nardi, Matteo Pagnesi, Mauro Riccardi, Giuseppe Vergaro, Enrico Vizzardi, Michele Emdin, Marco Metra
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
An increasing awareness of the disease, new diagnostic tools and novel therapeutic opportunities have dramatically changed the management of patients with amyloid transthyretin cardiomyopathy (ATTR-CM). Supportive therapies have shown limited benefit
Externí odkaz:
https://doaj.org/article/af43d5d163db4c218c962bab35d93d96
Autor:
Daniela Tomasoni, Julie K.K. Vishram‐Nielsen, Matteo Pagnesi, Marianna Adamo, Carlo Mario Lombardi, Finn Gustafsson, Marco Metra
Publikováno v:
ESC Heart Failure, Vol 9, Iss 3, Pp 1507-1523 (2022)
Abstract Heart failure (HF) is a major cause of mortality, hospitalizations, and reduced quality of life and a major burden for the healthcare system. The number of patients that progress to an advanced stage of HF is growing. Only a limited proporti
Externí odkaz:
https://doaj.org/article/207c4ed3634e4075b6feb207339b0b7a